Pro Share Advisors LLC Cti Biopharma Corp Transaction History

Pro Share Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$4.2 - $6.01 $4,615 - $6,604	-1,099 Reduced 8.53%	11,786 $49,000
Q4 2022 Feb 02, 2023	BUY	$4.45 - $6.17 $8,219 - $11,395	1,847 Added 16.73%	12,885 $77,000
Q3 2022 Nov 04, 2022	BUY	$5.36 - $7.43 $3,392 - $4,703	633 Added 6.08%	11,038 $64,000
Q2 2022 Aug 01, 2022	BUY	$3.55 - $6.27 $36,937 - $65,239	10,405 New	10,405 $62,000

Ticker CTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,385,000
Market Cap $1.04B
Description
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pro Share Advisors LLC with notifications on news.